2021
DOI: 10.25248/reas.e5410.2021
|View full text |Cite
|
Sign up to set email alerts
|

Fatores de risco, proteção, diagnóstico e tratamento da depressão pós-parto no contexto da atenção primária

Abstract: Objetivo: Buscar informações acerca dos fatores de risco e de proteção para a DPP, formas de diagnóstico e tratamentos, indicando, assim, os níveis de evidência nas pesquisas. Métodos: Trata-se de uma revisão bibliográfica baseada em estudos publicados de 2015-2020, nas bases de dados PubMed, Literatura latino-americana e do caribe em ciências da saúde (LILACS) e Scientific Electronic Library Online (Scielo). Resultados: Foram identificados 96 estudos, desses, 12 foram selecionados com base nos critérios de in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
(1 reference statement)
0
2
0
Order By: Relevance
“…According to Campos et al (2021), there was positive evidence regarding cognitive behavioral therapy in the puerperal period in these patients, which facilitated the self-knowledge of these pregnant women, consequently, the ability to deal with the symptoms. Pharmacological treatment may vary according to the degree of psychiatric disorder presented in each patient.…”
Section: Consequencesmentioning
confidence: 99%
See 1 more Smart Citation
“…According to Campos et al (2021), there was positive evidence regarding cognitive behavioral therapy in the puerperal period in these patients, which facilitated the self-knowledge of these pregnant women, consequently, the ability to deal with the symptoms. Pharmacological treatment may vary according to the degree of psychiatric disorder presented in each patient.…”
Section: Consequencesmentioning
confidence: 99%
“…(GUEDES-SILVA et al, 2003). Selective serotonin and noradrenaline inhibitors (SNRIs), Venlafaxine, are recommended for women who breastfeed, while for those who do not breastfeed, treatment similar to that of an adult with depression can be followed (CAMPOS, et al, 2021).…”
Section: Consequencesmentioning
confidence: 99%